Lung Cancer Clinical Trial
Neoadjuvant Immunotherapy in Advanced NSCLC
Summary
A number of clinical trials have demonstrated the efficacy of immunotherapy prior as neoadjuvant therapy. This study evaluates whether said neoadjuvant immunotherapy may improve improve progression free survival in NSCLC. One such example would be to evaluate either single agent or an immunotherapy combination with chemotherapy. Following this, analysis of biomarkers will be conducted to provide personalization in one's regimen.
Full Description
A number of clinical trials have demonstrated the efficacy of immunotherapy prior as neoadjuvant therapy. This study evaluates whether said neoadjuvant immunotherapy may improve improve progression free survival in NSCLC. [The Power Life Sciences Investigative Team](https://www.withpower.com) is running a study to evaluate either single agent or an immunotherapy combination with chemotherapy. Patients can contact a site administrator via the information below, or enroll directly via https://www.withpower.com/trial/phase-4-2019-e67c1. Following this, analysis of biomarkers will be conducted to provide personalization in one's regimen.
Eligibility Criteria
Inclusion Criteria:
>= 18 Years of Age
Informed consent is provided
Histologically confirmed resectable non-small cell lung cancer with stage II-IIIA (TNM 8th edition)
Eastern Cooperative Oncology Group (ECOG) performance status 0-1
Epidermal growth factor receptor (EGFR) mutation negative and anaplastic lymphoma kinase (ALK) translocation negative
Exclusion Criteria:
EGFR mutation positive and ALK translocation positive
Active central nervous system (CNS) metastases
Autoimmune diseases
Inhaled or topical steroids, and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active autoimmune disease
Patients with interstitial lung disease will not be included if they have symptomatic interstitial lung disease (ILD) - Grade 3-4
Women who are breast feeding or pregnant
Sexually active women or men of childbearing potential who are not willing to use an effective contraceptive method during the study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.